Polaris AI Pharma Corp. (KOSDAQ:041910)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,860.00
+100.00 (1.48%)
Last updated: Aug 8, 2025
1.48%
Market Cap89.80B
Revenue (ttm)63.94B
Net Income (ttm)989.48M
Shares Out13.28M
EPS (ttm)84.72
PE Ratio79.80
Forward PEn/a
Dividend100.00 (1.48%)
Ex-Dividend Daten/a
Volume12,466
Average Volume49,753
Open6,830.00
Previous Close6,760.00
Day's Range6,730.00 - 6,880.00
52-Week Range4,810.00 - 9,800.00
Beta0.84
RSI33.59
Earnings DateMar 21, 2025

About Polaris AI Pharma

Polaris AI Pharma Corp. engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally. It also offers its products for various therapeutic categories, such as diagnostic acid, antidiabetic, anti-depressants, and cholinergic. The company was formerly known as EstechPharma Co., Ltd. and changed its name to Polaris AI Pharma Corp. in March 2024. The company was founded in 1996 and is headquartered in Hwaseong-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 160
Stock Exchange KOSDAQ
Ticker Symbol 041910
Full Company Profile

Financial Performance

In 2021, Polaris AI Pharma's revenue was 60.40 billion, a decrease of -1.51% compared to the previous year's 61.32 billion. Earnings were 6.87 billion, a decrease of -56.30%.

Financial Statements

News

There is no news available yet.